Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $43,363 | $44,706 | $40,709 | $38,606 |
| % Growth | -3% | 9.8% | 5.4% | – |
| Cost of Goods Sold | $24,234 | $25,252 | $22,301 | $20,300 |
| Gross Profit | $19,129 | $19,454 | $18,408 | $18,306 |
| % Margin | 44.1% | 43.5% | 45.2% | 47.4% |
| R&D Expenses | $0 | $162 | $214 | $433 |
| G&A Expenses | $3,953 | $3,633 | $1,677 | $1,481 |
| SG&A Expenses | $10,992 | $10,100 | $4,599 | $4,396 |
| Sales & Mktg Exp. | $7,039 | $6,467 | $2,922 | $2,915 |
| Other Operating Expenses | $6,700 | $2,194 | $0 | $0 |
| Operating Expenses | $17,692 | $12,456 | $9,465 | $9,468 |
| Operating Income | $1,437 | $6,998 | $7,822 | $8,671 |
| % Margin | 3.3% | 15.7% | 19.2% | 22.5% |
| Other Income/Exp. Net | -$1,560 | -$1,284 | -$1,267 | -$537 |
| Pre-Tax Income | -$123 | $5,714 | $6,555 | $8,134 |
| Tax Expense | $960 | $1,310 | $1,327 | $1,646 |
| Net Income | -$1,083 | $4,404 | $5,228 | $6,488 |
| % Margin | -2.5% | 9.9% | 12.8% | 16.8% |
| EPS | -2.44 | 9.91 | 11.77 | 14.32 |
| % Growth | -124.6% | -15.8% | -17.8% | – |
| EPS Diluted | -2.44 | 9.91 | 11.77 | 14.32 |
| Weighted Avg Shares Out | 444 | 444 | 444 | 453 |
| Weighted Avg Shares Out Dil | 444 | 444 | 444 | 453 |
| Supplemental Information | – | – | – | – |
| Interest Income | $358 | $999 | $509 | $92 |
| Interest Expense | $1,649 | $2,227 | $1,324 | $765 |
| Depreciation & Amortization | $635 | $1,973 | $1,788 | $1,713 |
| EBITDA | $2,161 | $9,914 | $9,667 | $10,612 |
| % Margin | 5% | 22.2% | 23.7% | 27.5% |